Regina Katzenschlager

Donauspital — Austria

Medicine · Health Sciences

49h-index13.5kcitations123works6.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Parkinson's Disease Mechanisms and Treatments(84), Neurological disorders and treatments(62), Genetic Neurodegenerative Diseases(16), Botulinum Toxin and Related Neurological Disorders(14), Autism Spectrum Disorder Research(11)

Publications123 total

Revisiting the 2015 MDS diagnostic criteria for Parkinson disease: insights from autopsy-confirmed cases
npj Parkinson s Disease·2025Open Access
Reply: “Treatment Options for Motor Fluctuations in Parkinson's Disease”
Movement Disorders·2025
Continuous subcutaneous infusion therapies in Parkinson's disease: evidence of efficacy and safety
Parkinsonism & Related Disorders·2025· 5 cited
Update on Treatments for Parkinson's Disease Motor Fluctuations – An International Parkinson and Movement Disorder Society Evidence‐Based Medicine Review
Movement Disorders·2025· 32 citedOpen Access
Prof. DDr. Gregor K. Wenning (1964–2024)
Journal of Neural Transmission·2024Open Access
Apomorphine infusion in Parkinson's disease: An update
International review of movement disorders·2024· 1 cited
Differential diagnosis of chorea (guidelines of the German Neurological Society)
Neurological Research and Practice·2023· 10 citedOpen Access
Symptomatic treatment options for Huntington’s disease (guidelines of the German Neurological Society)
Neurological Research and Practice·2023· 28 citedOpen Access
Medikamentöse Frühtherapie des Morbus Parkinson
psychopraxis neuropraxis·2023
Practical use of apomorphine infusion in Parkinson’s disease: lessons from the TOLEDO study and clinical experience
Journal of Neural Transmission·2023· 19 citedOpen Access
Are Parkinson’s disease patients referred too late for device-aided therapies and how can better informed and earlier referrals be encouraged?
Journal of Neural Transmission·2023· 5 cited
Lyme neuroborreliosis: Progressive cerebral vasculitis responsive to cyclophosphamide. A case report and review of the literature
Journal of Stroke and Cerebrovascular Diseases·2023· 5 cited
Levodopa Dose Equivalency in Parkinson's Disease: Updated Systematic Review and Proposals
Movement Disorders·2023· 294 citedOpen Access
Pharmacological Treatment of Tremor in Parkinson’s Disease Revisited
Journal of Parkinson s Disease·2023· 79 citedOpen Access
Temporal Trends of Functional Outcome in Patients With Acute Ischemic Stroke Treated With Intravenous Thrombolysis
Stroke·2022· 14 citedOpen Access
Zerebrovaskuläre Komplikationen bei Neuroborreliose
psychopraxis neuropraxis·2022Open Access
Time trends in stroke severity in the years 2005 to 2020: results from the Austrian Stroke Unit Registry
Journal of Neurology·2022· 18 cited
Safinamide in the treatment pathway of Parkinson’s Disease: a European Delphi Consensus
npj Parkinson s Disease·2022· 26 citedOpen Access
Long-term safety and efficacy of apomorphine infusion in Parkinson's disease patients with persistent motor fluctuations: Results of the open-label phase of the TOLEDO study
Parkinsonism & Related Disorders·2021· 75 citedOpen Access
The Choice Between Advanced Therapies for Parkinson’s Disease Patients: Why, What, and When?
Journal of Parkinson s Disease·2020· 69 citedOpen Access
page 1 of 7Next →

Frequent Co-authors

Andrew J. Lees(22), Werner Poewe(14), К. Ray Chaudhuri(9), Olivier Rascol(8), Andrew Evans(8), Per Odin(8), Klaus Seppi(7), Claudia Trenkwalder(7), Cristina Sampaio(6), Walter Pirker(6), Günther Deuschl(6), Tove Henriksen(6), Angelo Antonini(6), Daniel Weintraub(5), Kailash P. Bhatia(5), Miguel Coelho(4), Susan H. Fox(4), Eduardo Tolosa(4), Niall Quinn(4), Fabrizio Stocchi(4)